Skip to main content
. 2024 Jan 18;52(3):1009–1026. doi: 10.1007/s15010-023-02156-y

Table 1.

Distribution of risk factors among included studies

Risk factor Total number of analyses in all studies Studies including analyses of risk factorsa
Cancer 20 [45, 49, 51, 52, 57, 86, 89, 93, 103]
Diabetes 17 [13, 38, 41, 45, 49, 51, 52, 56, 59, 73, 82, 92, 94, 99, 100, 103]
Autoimmune disorders 16 [40, 45, 49, 51, 52, 77, 86, 90, 92, 103]
Mental health condition 15 [38, 44, 74, 85, 106, 109, 110, 113, 114]
Musculoskeletal disorders 14 [51, 52, 81, 86, 9597, 99, 103, 107]
RA 13 [13, 49, 51, 52, 69, 80, 86, 88, 89, 92]
HIV 12 [37, 4547, 63, 71, 82, 86, 89, 92, 94, 103]
Asthma 11 [13, 43, 45, 51, 52, 68, 92, 101103, 112]
Cardiovascular disorders 11 [13, 45, 49, 51, 52, 99, 103, 111]
Digestive disorders 11 [38, 53, 55, 58, 61, 65, 72, 90, 103]
COPD 10 [13, 45, 51, 52, 67, 75, 85, 92, 99, 103],
Transplantation 10 [36, 48, 51, 52, 82, 86, 89, 92]
SLE 10 [39, 42, 49, 51, 52, 66, 69, 86, 89, 92]
Renal disorders 10 [49, 51, 52, 62, 84, 86, 87, 92, 104, 105]
Depression 9 [13, 51, 52, 91, 92, 99, 106, 109, 110]
Endocrine and metabolic disorders 8 [5052, 86, 99]
IBD 8 [51, 52, 55, 64, 72, 86, 89, 92]
CHF 7 [13, 45, 51, 52, 83, 103, 111]
Hematological disorders 7 [60, 92, 94, 98]
Neurological disorders 6 [51, 52, 54, 78, 79, 103]
Psoriasis 6 [51, 52, 76, 86, 89, 108]

RA, rheumatoid arthritis; COPD, chronic obstructive pulmonary disorder; SLE, systemic lupus erythematosus; IBD, inflammatory bowel disease; CHF, chronic heart failure

aPlease note that a single study may include both analyses of multiple risk factors and multiple analyses of the same risk factor